Johns Hopkins HIV Guide
Glecaprevir + Pibrentasvir
Glecaprevir + Pibrentasvir is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of adult patients with chronic HCV infection (genotypes 1, 2, 3, 4, 5, or 6) without cirrhosis or compensated cirrhosis (Child-Pugh A).
- Treatment of adult patients with HCV Genotype 1 infection previously treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of adult patients with chronic HCV infection (genotypes 1, 2, 3, 4, 5, or 6) without cirrhosis or compensated cirrhosis (Child-Pugh A).
- Treatment of adult patients with HCV Genotype 1 infection previously treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 10, 2018
Citation
Dzintars, Kathryn. "Glecaprevir + Pibrentasvir." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir.
Dzintars K. Glecaprevir + Pibrentasvir. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir. Accessed August 16, 2022.
Dzintars, K. (2018). Glecaprevir + Pibrentasvir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir
Dzintars K. Glecaprevir + Pibrentasvir [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2022 August 16]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Glecaprevir + Pibrentasvir
ID - 545273
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2018/07/10/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
